Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | IBRX | HUBS |
|---|---|---|
| Price | $10.38 | $220.61 |
| Change today | ▲ 0.92% | ▲ 2.83% |
| Market cap | $11.00B | $11.00B |
| Return, 3 months | +18.5% | +7.5% |
| Return, year to date | +424.2% | -45.0% |
| Return, 1 year | +310.3% | -52.4% |
| P/E (TTM) | -10.9 | 78.5 |
| P/B | -10.5 | 6.6 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | – | – |
| Analyst buy share | – | – |
| RSI (14) | 71 | 49 |
| 30-day volatility | 67.6% | 62.8% |
| Max drawdown, 1 year | -42.3% | -67.2% |
| Trend read | Strong uptrend | Strong downtrend |
| Analyst consensus | – | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
